Want to see JP:5187 full AI Analyst Report?
Top Page
Create Medic Co., Ltd.
(5187)
Select Model
Select Model
Rating:70Outperform
Price Target:
¥1,254.00
▲(20.93% Upside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by solid financial stability from a low-leverage balance sheet and steady revenue growth, partially offset by uneven profitability and inconsistent cash generation (including a sharp cash flow decline in 2025). Technicals are supportive with price holding above key moving averages and positive MACD, and valuation is helped by a moderate P/E and a strong dividend yield.
Positive Factors
Recurring Consumables Demand
The single-use nature of its infusion, transfusion, drainage and catheter-care products creates recurring replenishment demand. This supports revenue visibility because hospitals and clinics must continue purchasing supplies as procedures and patient care activities occur.
Negative Factors
Inconsistent Cash Generation
Uneven cash conversion can constrain the funds available for product development, capital spending and shareholder returns. The 2025 decline also raises execution risk around working capital or investment spending, even though the balance sheet remains conservative.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring Consumables Demand
The single-use nature of its infusion, transfusion, drainage and catheter-care products creates recurring replenishment demand. This supports revenue visibility because hospitals and clinics must continue purchasing supplies as procedures and patient care activities occur.
Read all positive factors
Create Medic Co., Ltd. (5187) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.40B
Dividend Yield4.2%
Average Volume (3M)6.22K
Price to Earnings (P/E)16.9
Beta (1Y)0.28
Revenue Growth5.20%
EPS Growth-17.92%
CountryJP
Employees1,010
SectorHealthcare
Sector Strength45
IndustryMedical - Specialties
Share Statistics
EPS (TTM)67.54
Shares Outstanding9,664,327
10 Day Avg. Volume5,490
30 Day Avg. Volume6,220
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.53
Price to Sales (P/S)0.64
P/FCF Ratio88.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Create Medic Co., Ltd. Business Overview & Revenue Model
Company Description
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman,...
How the Company Makes Money
Create Medic primarily makes money by selling medical devices and single-use medical consumables to healthcare providers (e.g., hospitals and clinics) through domestic and export distribution channels. Its core revenue comes from recurring demand ...
Create Medic Co., Ltd. Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
83
Very Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.99B | 13.62B | 13.03B | 12.59B | 12.33B | 11.70B |
| Gross Profit | 5.85B | 5.99B | 5.70B | 5.48B | 5.37B | 5.26B |
| EBITDA | 1.39B | 1.64B | 1.73B | 1.50B | 1.47B | 1.43B |
| Net Income | 560.97M | 713.73M | 840.90M | 154.02M | 482.21M | 660.41M |
Balance Sheet | ||||||
| Total Assets | 20.14B | 20.14B | 20.05B | 19.26B | 19.12B | 18.08B |
| Cash, Cash Equivalents and Short-Term Investments | 5.64B | 5.83B | 6.32B | 4.39B | 4.31B | 4.36B |
| Total Debt | 749.70M | 749.70M | 891.96M | 884.78M | 933.42M | 815.36M |
| Total Liabilities | 3.65B | 3.81B | 4.30B | 4.31B | 4.40B | 3.86B |
| Stockholders Equity | 16.49B | 16.33B | 15.75B | 14.94B | 14.72B | 14.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 98.51M | 1.77B | 246.98M | 101.75M | 629.58M |
| Operating Cash Flow | 0.00 | 530.12M | 2.25B | 698.84M | 461.34M | 1.25B |
| Investing Cash Flow | 0.00 | -573.08M | 270.62M | -363.61M | 38.01M | -585.01M |
| Financing Cash Flow | 0.00 | -600.39M | -877.65M | -362.19M | -355.59M | -442.52M |
Create Medic Co., Ltd. Technical Analysis
Positive
1037.00
Price Trends
1133.88
Positive
1126.03
Positive
1096.65
Positive
Market Momentum
3.33
Positive
52.87
Neutral
62.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5187, the sentiment is Positive. The current price of 1037 is below the 20-day moving average (MA) of 1139.80, below the 50-day MA of 1133.88, and below the 200-day MA of 1096.65, indicating a bullish trend. The MACD of 3.33 indicates Positive momentum. The RSI at 52.87 is Neutral, neither overbought nor oversold. The STOCH value of 62.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5187.
Create Medic Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥17.39B | 11.54 | ― | 6.32% | 20.88% | 44.61% | |
70 Outperform | ¥10.40B | 16.94 | ― | 4.20% | 5.20% | -17.92% | |
63 Neutral | ¥248.29B | 18.10 | ― | 2.11% | 1.43% | 1.86% | |
57 Neutral | ¥77.18B | 21.71 | ― | 2.48% | 2.94% | 57.05% | |
54 Neutral | ¥17.59B | -79.81 | ― | 2.54% | -6.64% | 67.08% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | ¥182.84B | 19.82 | 5.76% | 2.92% | 3.04% | -19.26% |
* Healthcare Sector Average
JP:5187
Create Medic Co., Ltd.
1,144.00
186.33
19.46%
JP:6523
PHC Holdings Corp.
1,436.00
370.21
34.74%
JP:4549
Eiken Chemical Co., Ltd.
2,341.00
-91.72
-3.77%
JP:6678
Techno Medica Co., Ltd.
2,040.00
50.05
2.52%
JP:6849
Nihon Kohden Corporation
1,514.50
-179.38
-10.59%
JP:7600
Japan Medical Dynamic Marketing, Inc.
668.00
167.15
33.37%
Create Medic Co., Ltd. Corporate Events
Create Medic’s First-Half Profit Slides as Margins Tighten but Dividend Rises
Aug 5, 2026
Create Medic reported consolidated net sales of ¥6,932 million for the six months ended June 30, 2026, up 5.6% year on year, but operating profit fell 38.6% to ¥336 million and profit attributable to owners of parent dropped 37.0% to ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.